miR‑181a‑5p regulates the proliferation and apoptosis of glomerular mesangial cells by targeting KLF6

  • Authors:
    • Xinyue Liang
    • Wen Xu
  • View Affiliations

  • Published online on: May 21, 2020     https://doi.org/10.3892/etm.2020.8780
  • Pages: 1121-1128
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Diabetic nephropathy (DN) is a chronic loss of kidney function that frequently occurs in patients with diabetes mellitus and is characterized by abnormal glomerular mesangial cell (GMC) proliferation and apoptosis. By using microarray analysis, microRNA (miR)‑181a‑5p has previously been identified to be dysregulated in DN. The present study aimed to determine the underlying molecular mechanisms and function of miR‑181a‑5p in GMCs under DN conditions. First, reverse transcription‑quantitative PCR was performed to detect miR‑181a‑5p and kruppel‑like factor 6 (KLF6) expression in GMCs following high‑glucose treatment. Subsequently, MTT and flow cytometric assays were performed in order to determine the effect of miR‑181a‑5p and KLF6 on high‑glucose‑driven GMC proliferation and apoptosis. After confirming that KLF6 was a target gene of miR‑181a‑5p via a bioinformatics analysis and luciferase reporter assay, the mRNA and protein expression levels of associated factors in different treatment groups were measured. The results demonstrated that miR‑181a‑5p was significantly downregulated, while KLF6 was significantly upregulated in GMCs following treatment with high glucose. Furthermore, overexpression of miR‑181a led to suppression of cell proliferation and promoted apoptosis of GMCs induced by high glucose, while these effects were inhibited by co‑transfection with KLF6. Finally, miR‑181‑5p was demonstrated to inhibit the expression of KLF6, Bcl‑2, Wnt1 and β‑catenin, while increasing the expression levels of Bax and caspase‑3. In conclusion, the expression levels of miR‑181a‑5p were downregulated in GMCs following treatment with high glucose and overexpression of miR‑181a‑5p may inhibit GMC proliferation and promote apoptosis, at least partially through targeting KLF6 via the Wnt/β‑catenin signaling pathway. Overall, the results of the present study suggest that miR‑181a‑5p may have a crucial role in the occurrence and development of DN and may be a valuable diagnostic marker and therapeutic target for DN.

Related Articles

Journal Cover

August-2020
Volume 20 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liang X and Liang X: miR‑181a‑5p regulates the proliferation and apoptosis of glomerular mesangial cells by targeting KLF6. Exp Ther Med 20: 1121-1128, 2020
APA
Liang, X., & Liang, X. (2020). miR‑181a‑5p regulates the proliferation and apoptosis of glomerular mesangial cells by targeting KLF6. Experimental and Therapeutic Medicine, 20, 1121-1128. https://doi.org/10.3892/etm.2020.8780
MLA
Liang, X., Xu, W."miR‑181a‑5p regulates the proliferation and apoptosis of glomerular mesangial cells by targeting KLF6". Experimental and Therapeutic Medicine 20.2 (2020): 1121-1128.
Chicago
Liang, X., Xu, W."miR‑181a‑5p regulates the proliferation and apoptosis of glomerular mesangial cells by targeting KLF6". Experimental and Therapeutic Medicine 20, no. 2 (2020): 1121-1128. https://doi.org/10.3892/etm.2020.8780